.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The Aster DM Healthcare merger with Quality Care India Ltd (QCIL) is driving significant financial growth. Specifically, the company reported an 18% year-on-year revenue increase for Q4 FY26, reaching Rs 1,182 crore. Operating EBITDA rose 31% to Rs 253 crore. These results highlight a period of robust expansion and operational efficiency for the healthcare giant.
The consolidation process remains on schedule for completion by the first quarter of FY27. Consequently, the combined entity will operate over 10,600 beds across 28 Indian cities. This scale positions the group among the top three healthcare providers in the country. Furthermore, a pipeline of 4,400 additional beds will support future demand. Shareholders have shown overwhelming support, with 96.68% voting in favor of the vision. This confidence reflects the strategic value of creating an integrated healthcare platform.
Higher patient volumes and improved realisations primarily fueled growth during the quarter. For instance, the average revenue per inpatient (ARPOB) increased by 9% to Rs 1.25 lakh. Total patient volumes also grew by 15%. Regionally, the Kerala and Andhra Pradesh-Telangana clusters were the strongest performers. Moreover, the group's margin improved to 21.7% from 19.3% in the previous year. This improvement stems from strong cost discipline and operating leverage. Investors like Blackstone continue to back the merger as it moves through regulatory approvals.
Q1: When will the merger between Aster DM Healthcare and QCIL be completed?
The company expects to close the merger in the first quarter of FY27, pending final regulatory approvals.
Q2: How many beds will the combined healthcare platform manage?
The combined platform will have over 10,600 beds across 28 cities, with an additional pipeline of 4,400 beds.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Aster DM Healthcare reports 18% Q4 revenue growth as the Quality Care India merger nears completion, creating a top-tier Indian healthcare platform....
5 months ago
Explore vital recurrent stroke predictors in lacunar stroke patients managed with intensive blood pressure lowering. This analysis examines trial findings from SPS3 to uncover residual vascular risks, metabolic factors, and targeted secondary prevention strategies for high-risk neurological patients.
Today
A comprehensive scoping review synthesises evidence linking prenatal maternal mental health to long-term offspring neurodevelopment, evaluating neuroendocrine, inflammatory, and epigenetic pathways while highlighting clinical screening and future research priorities.
Today
The Directorate General of Health Services directs Indian states to halt the hazardous reuse and reprocessing of single-use medical devices. Discover regulatory implications under the Drugs and Cosmetics Act, critical infection risks, legal liabilities, and operational changes required across clinical specialties.
Today
Mitochondria-targeted nanoparticles self-assembled from EGCG and L-glutamic acid effectively restore mitochondrial homeostasis, suppress synovial inflammation, and attenuate chondrocyte senescence in osteoarthritis, offering a promising disease-modifying nanotherapy.
Today
India is advancing preventive healthcare by integrating genomics, artificial intelligence, and quantum technologies. With the SANGAM programme sequencing one million Indian genomes, clinicians can unlock personalized therapies, detect cardiometabolic risks early, and curb the burden of diabetes and heart disease.
Today
